The following search results are from Street Authority's public research only. Please Log In to search your premium services.

Results

Looking over the most recent short-interest data, a very unusual company jumped out at me: EMC Corp. (NYSE: EMC). Short-sellers are increasingly convinced the storage giant is headed for a fall. In the last two weeks of April, they boosted the short position in EMC by 18%… Read More

Berkshire Hathaway (NYSE: BRK-A) (NYSE: BRK-B) released its latest 13-F filing with the Securities and Exchange Commission (SEC) on Monday, May 16, to detail its stock portfolio holdings as of the end of the first quarter. The release is highly-anticipated each quarter and, though the first quarter ended more than six weeks ago, it offers the timeliest way to see which stocks Warren Buffett bought, sold or held during the 12-week period. The latest twist at Berkshire is that Warren Buffett hired 39 year-old Todd Combs from CastlePoint Capital Management back… Read More

Berkshire Hathaway (NYSE: BRK-A) (NYSE: BRK-B) released its latest 13-F filing with the Securities and Exchange Commission (SEC) on Monday, May 16, to detail its stock portfolio holdings as of the end of the first quarter. The release is highly-anticipated each quarter and, though the first quarter ended more than six weeks ago, it offers the timeliest way to see which stocks Warren Buffett bought, sold or held during the 12-week period. The latest twist at Berkshire is that Warren Buffett hired 39 year-old Todd Combs from CastlePoint Capital Management back in October 2010 to help him manage Berkshire’s $53.6 billion portfolio. As such, this represented the first full quarter in which Combs’ picks will be commingled with Buffett’s. Previously, Lou Simpson from Berkshire insurance subsidiary Geico had picks that showed up in Berkshire’s quarterly filing, but Simpson retired in August 2010 at the age of 73. #-ad_banner-#Only three stock trades took place during Berkshire’s first quarter. The first consisted of a sale of integrated energy firm ConocoPhillips (NYSE: COP), which Buffett has been steadily selling off over since an admitted bad call on his part when he… Read More

When analysts received word on March 30 that Medicare would cover Dendreon’s (Nasdaq: DNDN) pricey drug Provenge, used to treat prostate cancer, shares of the drug maker steadily rose from $35 to $43 in just one month. Read More

Despite the recent bearish effort, the stock market‘s still up 6% for the year. Some sectors and groups, however, are up more than others. Such outperformance begs the question: are these leading industries already over-baked, or is… Read More